首页> 外文期刊>Bone marrow transplantation >Infectious complications and outcomes after allogeneic hematopoietic stem cell transplantation in Korea.
【24h】

Infectious complications and outcomes after allogeneic hematopoietic stem cell transplantation in Korea.

机译:韩国同种异体造血干细胞移植后的感染并发症和结果。

获取原文
获取原文并翻译 | 示例
       

摘要

We reviewed 242 allogeneic hematopoietic stem cell transplantation (HSCT) recipients retrospectively over a 2-year period (January 1998-December 1999) in order to analyze the characteristics and assess the outcomes of infectious complications in patients after HSCT in Korea. Bacteria were the major pathogens before engraftment, and viral and fungal infections predominated during the post-engraftment period. Varicella zoster virus was the most common viral pathogen after engraftment. Cytomegalovirus disease occurred mainly in the late-recovery phase. The frequency of mold infection was higher than that of yeast. There was a relatively high incidence of tuberculosis (3.0%) and Pneumocystis carinii pneumonia (6.5%). One case of death by measles confirmed by autopsy was also noted. Overall, cumulative mortality was 43% (104/242), and 59.6% of these deaths (62/104) were infection-related. Allogeneic HSCT recipients from unrelated donors were prone to infectious complication and higher mortality than those from matched sibling (17/39 (43.6%) vs 45/203 (22.2%), respectively; P<0.01; odd ratio 2.5; 95% confidence interval 1.2-5.1). As infection was the main post-HSCT complication in our data, more attention should be given to the management of infections in HSCT recipients.
机译:我们分析了两年内(1998年1月至1999年12月)的242名同种异体造血干细胞移植(HSCT)接受者,以分析其特征并评估韩国HSCT术后患者的感染并发症。细菌是植入前的主要病原体,在植入后期间病毒和真菌感染占主导地位。水痘带状疱疹病毒是植入后最常见的病毒病原体。巨细胞病毒病主要发生在恢复后期。霉菌感染的频率高于酵母菌。肺结核和卡氏肺孢子虫肺炎的发生率相对较高(3.0%)(6.5%)。还注意到一例经尸检证实的麻疹死亡病例。总体而言,累积死亡率为43%(104/242),其中这些死亡的59.6%(62/104)与感染有关。来自不相关供者的同种异体HSCT接受者比同胞同伴更容易发生感染并发症和更高的死亡率(分别为17/39(43.6%)和45/203(22.2%); P <0.01;奇数比2.5; 95%置信区间1.2-5.1)。由于在我们的数据中,感染是HSCT术后的主要并发症,因此应更加注意HSCT接受者的感染管理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号